Scarica l'app Stockscreener
6.05
3.51%
-0.22
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Optimizerx Corp Borsa (OPRX) Ultime notizie
OptimizeRx Corp (OPRX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
OptimizeRx Corp (OPRX) Cash Flow - TradingKey
OptimizeRx Corp (OPRX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
OPRX|OptimizeRx Corp|Price:6.375|Chg%:+0.135 - TradingKey
OptimizeRx Corp (OPRX) Valuation: PE, PB & Fair Value Analysis - TradingKey
OptimizeRx Corp (OPRX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
OptimizeRx Corp (OPRX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
OptimizeRx Corp (OPRX) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
TradingKey - TradingKey
OptimizeRx Corp (OPRX) Income Statement - TradingKey
OptimizeRx Corp (OPRX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
OptimizeRx appoints Sarah Bast as chief marketing officer By Investing.com - Investing.com Nigeria
OptimizeRx appoints Sarah Bast as chief marketing officer - Investing.com
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer - The Manila Times
Sarah Bast Brings More Than Two Decades of Pharma Marketing to OptimizeRx - Stock Titan
Royce & Associates (OPRX) discloses 1.09M-share passive stake in OptimizeRx - Stock Titan
Mariyamma Varghese Presti Net Worth (2026) - GuruFocus
OptimizeRx's Q4 Beat: A Closer Look at the Numbers - Kavout | AI
OptimizeRx Company Profile & Introduction - Moomoo
OptimizeRx Corp. Hits New 52-Week Low at $4.54 Amid Market Struggles - MarketsMojo
OptimizeRx stock rises after launching CopayCue product By Investing.com - Investing.com South Africa
OptimizeRx stock rises after launching CopayCue product - Investing.com
OptimizeRx launches CopayCue for prescription savings - Investing.com
OptimizeRx launches CopayCue for prescription savings By Investing.com - Investing.com Nigeria
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent - The Manila Times
OptimizeRx Launches CopayCue to Deliver Brand Savings Offers at the Point of Prescribing - Quiver Quantitative
OptimizeRx ties copay offers to physician intent at prescribing moment - Stock Titan
OptimizeRx Corporation (OPRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
Stifel reiterates Buy on OptimizeRX stock, cites AI tool launch By Investing.com - Investing.com South Africa
OptimizeRx stock rating maintained at Market Outperform by Citizens - Investing.com Nigeria
OptimizeRx Corporation(NasdaqCM: OPRX) dropped from Russell 2000 Dynamic Index - marketscreener.com
OptimizeRx Corp (OPRX) Institutional Confidence - TradingKey
OptimizeRx Announced the Launch of Natural Language Audience Builder - MarTech Cube
OptimizeRx Launches Natural Language Audience Builder for Life Sciences DSPs and Agency Media Planning Platforms - The Manila Times
OptimizeRx Launches AI-Powered Natural Language Audience Builder for DSP and Media Planning Platforms - Quiver Quantitative
Citizens reiterates Market Outperform on OptimizeRX stock at forum By Investing.com - Investing.com Australia
Citizens reiterates Market Outperform on OptimizeRX stock at forum - Investing.com
OptimizeRx StockAnalyst expectations and recent price levels on a quiet news day - Ad-hoc-news.de
OptimizeRx Corp (OPRX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
OptimizeRx (OPRX) Stock Sees Fair Value Cut As Analysts Reset Growth Expectations - Yahoo Finance
OptimizeRx Expands EHR Advertising Reach With New DSP Integration - qz.com
OptimizeRx (NASDAQ: OPRX) holders add 1M plan shares, reject evergreen - Stock Titan
0.84%
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):